{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:51:11Z","timestamp":1792000271622,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100005292","name":"Brigham and Women's Hospital","doi-asserted-by":"publisher","award":["Women's Brain Initiative"],"award-info":[{"award-number":["Women's Brain Initiative"]}],"id":[{"id":"10.13039\/100005292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017641","name":"Mars Symbioscience","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017641","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-026-02570-8","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:23:29Z","timestamp":1791998609000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma biomarkers of neurodegeneration and physical performance in older adults"],"prefix":"10.1007","author":[{"given":"Alice C.","family":"von Alvensleben","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunjung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Kurth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryl S.","family":"LeBoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirah K.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Ran","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth L.","family":"Ostaszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis J.","family":"Selkoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard D.","family":"Sesso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoAnn E.","family":"Manson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3543-045X","authenticated-orcid":false,"given":"Pamela M.","family":"Rist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"issue":"101544","key":"2570_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101544","volume":"74","author":"YAR Mahaman","year":"2022","unstructured":"Mahaman YAR, Embaye KS, Huang F, Li L, Zhu F, Wang JZ, et al. Biomarkers used in Alzheimer\u2019s disease diagnosis, treatment, and prevention. Ageing Res Rev. 2022;74(101544): 101544.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"2570_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/brain\/awad267","volume":"147","author":"Y Jung","year":"2024","unstructured":"Jung Y, Damoiseaux JS. The potential of blood neurofilament light as a marker of neurodegeneration for Alzheimer\u2019s disease. Brain. 2024;147(1):12\u201325.","journal-title":"Brain"},{"issue":"5","key":"2570_CR3","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/ana.25885","volume":"88","author":"D Mengel","year":"2020","unstructured":"Mengel D, Janelidze S, Glynn RJ, Liu W, Hansson O, Walsh DM. Plasma NT1 tau is a specific and early marker of Alzheimer\u2019s disease. Ann Neurol. 2020;88(5):878\u201392.","journal-title":"Ann Neurol"},{"issue":"1","key":"2570_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19543-w","volume":"11","author":"JP Chhatwal","year":"2020","unstructured":"Chhatwal JP, Schultz AP, Dang Y, Ostaszewski B, Liu L, Yang HS, et al. Plasma N-terminal tau fragment levels predict future cognitive decline and neurodegeneration in healthy elderly individuals. Nat Commun. 2020;11(1): 6024.","journal-title":"Nat Commun"},{"issue":"5","key":"2570_CR5","doi-asserted-by":"publisher","first-page":"e473","DOI":"10.1212\/WNL.0000000000201479","volume":"100","author":"V Planche","year":"2023","unstructured":"Planche V, Bouteloup V, Pellegrin I, Mangin JF, Dubois B, Ousset PJ, et al. Validity and performance of blood biomarkers for Alzheimer disease to predict dementia risk in a large clinic-based cohort. Neurology. 2023;100(5):e473\u201384.","journal-title":"Neurology"},{"issue":"15","key":"2570_CR6","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1001\/jama.2024.13855","volume":"332","author":"S Palmqvist","year":"2024","unstructured":"Palmqvist S, Tideman P, Mattsson-Carlgren N, Schindler SE, Smith R, Ossenkoppele R, et al. Blood biomarkers to detect Alzheimer disease in primary care and secondary care. JAMA. 2024;332(15):1245\u201357.","journal-title":"JAMA"},{"issue":"2","key":"2570_CR7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/jnc.15128","volume":"159","author":"P Chatterjee","year":"2021","unstructured":"Chatterjee P, Cheong YJ, Bhatnagar A, Goozee K, Wu Y, McKay M. Plasma metabolites associated with biomarker evidence of neurodegeneration in cognitively normal older adults. J Neurochem. 2021;159(2):389\u2013402.","journal-title":"J Neurochem"},{"issue":"3","key":"2570_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14619","volume":"21","author":"KR Sewell","year":"2025","unstructured":"Sewell KR, Oberlin LE, Karikari TK, Olvera-Rojas M, Wan L, Morris JK. Blood biomarkers differentiate AD-related versus non-AD-related cognitive deficits. Alzheimers Dement. 2025;21(3):e14619.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"2570_CR9","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/alz.12724","volume":"19","author":"P Chatterjee","year":"2023","unstructured":"Chatterjee P, Pedrini S, Doecke JD, Thota R, Villemagne VL, Dor\u00e9 V. Plasma A\u03b242\/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer\u2019s disease continuum: a cross-sectional and longitudinal study in the AIBL cohort. Alzheimers Dement. 2023;19(4):1117\u201334.","journal-title":"Alzheimers Dement"},{"key":"2570_CR10","doi-asserted-by":"publisher","DOI":"10.1172\/JCI158453","author":"MM Gonzales","year":"2022","unstructured":"Gonzales MM, Garbarino VR, Pollet E, Palavicini JP, Kellogg DL Jr, Kraig E, et al. Biological aging processes underlying cognitive decline and neurodegenerative disease. J Clin Invest. 2022. https:\/\/doi.org\/10.1172\/JCI158453.","journal-title":"J Clin Invest"},{"issue":"8","key":"2570_CR11","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1093\/brain\/awab481","volume":"145","author":"A Snellman","year":"2022","unstructured":"Snellman A, Lantero-Rodriguez J, Emer\u0161i\u010d A, Vrillon A, Karikari TK, Ashton NJ, et al. N-terminal and mid-region tau fragments as fluid biomarkers in neurological diseases. Brain. 2022;145(8):2834\u201348.","journal-title":"Brain"},{"issue":"1","key":"2570_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000513008","volume":"84","author":"YL Xiong","year":"2021","unstructured":"Xiong YL, Meng T, Luo J, Zhang H. The potential of neurofilament light as a biomarker in Alzheimer\u2019s disease. Eur Neurol. 2021;84(1):6\u201315.","journal-title":"Eur Neurol"},{"issue":"16","key":"2570_CR13","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1039\/D4LC00287C","volume":"24","author":"AR Yslas","year":"2024","unstructured":"Yslas AR, Park R, Nishimura N, Lee E. Monomeric and oligomeric amyloid-\u03b2 cause distinct Alzheimer\u2019s disease pathophysiological characteristics in astrocytes in human glymphatics-on-chip models. Lab Chip. 2024;24(16):3826\u201339.","journal-title":"Lab Chip"},{"issue":"11","key":"2570_CR14","doi-asserted-by":"publisher","first-page":"e1123","DOI":"10.1212\/WNL.0000000000012482","volume":"97","author":"KJ Sullivan","year":"2021","unstructured":"Sullivan KJ, Blackshear C, Simino J, Tin A, Walker KA, Sharrett AR, et al. Association of midlife plasma amyloid-\u03b2 levels with cognitive impairment in late life: the ARIC neurocognitive study. Neurology. 2021;97(11):e1123\u201331.","journal-title":"Neurology"},{"issue":"3","key":"2570_CR15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","volume":"81","author":"NJ Ashton","year":"2024","unstructured":"Ashton NJ, Brum WS, Di Molfetta G, Benedet AL, Arslan B, Jonaitis E, et al. Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for Alzheimer disease pathology. JAMA Neurol. 2024;81(3):255\u201363.","journal-title":"JAMA Neurol"},{"issue":"3","key":"2570_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000154929","volume":"31","author":"TW Auyeung","year":"2008","unstructured":"Auyeung TW, Kwok T, Lee J, Leung PC, Leung J, Woo J. Functional decline in cognitive impairment--the relationship between physical and cognitive function. Neuroepidemiology. 2008;31(3):167\u201373.","journal-title":"Neuroepidemiology"},{"issue":"2","key":"2570_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1177\/0891988713481264","volume":"26","author":"TR Gure","year":"2013","unstructured":"Gure TR, Langa KM, Fisher GG, Piette JD, Plassman BL. Functional limitations in older adults who have cognitive impairment without dementia. J Geriatr Psychiatry Neurol. 2013;26(2):78\u201385.","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"22","key":"2570_CR18","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1001\/jama.2022.21680","volume":"328","author":"EJ Lenze","year":"2022","unstructured":"Lenze EJ, Voegtle M, Miller JP, Ances BM, Balota DA, Barch D, et al. Effects of mindfulness training and exercise on cognitive function in older adults: a randomized clinical trial. JAMA. 2022;328(22):2218\u201329.","journal-title":"JAMA"},{"issue":"4","key":"2570_CR19","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3233\/JAD-180622","volume":"65","author":"B Koychev","year":"2018","unstructured":"Koychev B, Galna H, Zetterberg J, Lawson G, Zamboni BH, Ridha BH. A\u03b242\/A\u03b240 and A\u03b242\/A\u03b238 ratios are associated with measures of gait variability and activities of daily living in mild Alzheimer\u2019s disease: a pilot study. J Alzheimers Dis. 2018;65(4):1377\u201383.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"2570_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1001\/jamaneurol.2016.3474","volume":"74","author":"NK Nadkarni","year":"2017","unstructured":"Nadkarni NK, Perera S, Snitz BE, Mathis CA, Price J, Williamson JD, et al. Association of brain amyloid-\u03b2 with slow gait in elderly individuals without dementia: influence of cognition and apolipoprotein E \u03b54 genotype. JAMA Neurol. 2017;74(1):82\u201390.","journal-title":"JAMA Neurol"},{"issue":"1","key":"2570_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1212\/WNL.0000000000002235","volume":"86","author":"N Del Campo","year":"2016","unstructured":"Del Campo N, Payoux P, Djilali A, Delrieu J, Hoogendijk EO, Rolland Y, et al. Relationship of regional brain \u03b2-amyloid to gait speed. Neurology. 2016;86(1):36\u201343.","journal-title":"Neurology"},{"issue":"1","key":"2570_CR22","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13195-020-00697-0","volume":"12","author":"L He","year":"2020","unstructured":"He L, de Souto BP, Aggarwal G, Nguyen AD, Morley JE, Li Y, et al. Plasma A\u03b2 and neurofilament light chain are associated with cognitive and physical function decline in non-dementia older adults. Alzheimers Res Ther. 2020;12(1):128.","journal-title":"Alzheimers Res Ther"},{"issue":"111431","key":"2570_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2021.111431","volume":"194","author":"J Titus","year":"2021","unstructured":"Titus J, Bray NW, Kamkar N, Camicioli R, Nagamatsu LS, Speechley M, et al. The role of physical exercise in modulating peripheral inflammatory and neurotrophic biomarkers in older adults: a systematic review and meta-analysis. Mech Ageing Dev. 2021;194(111431): 111431.","journal-title":"Mech Ageing Dev"},{"issue":"16","key":"2570_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21165895","volume":"21","author":"B Mahalakshmi","year":"2020","unstructured":"Mahalakshmi B, Maurya N, Lee SD, Bharath Kumar V. Possible neuroprotective mechanisms of physical exercise in neurodegeneration. Int J Mol Sci. 2020;21(16): 5895.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2570_CR25","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/brain\/awaa054","volume":"143","author":"F de Wolf","year":"2020","unstructured":"de Wolf F, Ghanbari M, Licher S, McRae-McKee K, Gras L, Weverling GJ, et al. Plasma tau, neurofilament light chain and amyloid-\u03b2 levels and risk of dementia; a population-based cohort study. Brain. 2020;143(4):1220\u201332.","journal-title":"Brain"},{"issue":"6","key":"2570_CR26","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1093\/ajcn\/nqac055","volume":"115","author":"HD Sesso","year":"2022","unstructured":"Sesso HD, Manson JE, Aragaki AK, Rist PM, Johnson LG, Friedenberg G. Effect of cocoa flavanol supplementation for the prevention of cardiovascular disease events: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial. Am J Clin Nutr. 2022;115(6):1490\u2013500.","journal-title":"Am J Clin Nutr"},{"key":"2570_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2022.106728","volume":"116","author":"PM Rist","year":"2022","unstructured":"Rist PM, Sesso HD, Johnson LG, Aragaki AK, Wang L, Rautiainen S. Design and baseline characteristics of participants in the COcoa Supplement and Multivitamin Outcomes Study (COSMOS). Contemp Clin Trials. 2022;116:106728.","journal-title":"Contemp Clin Trials"},{"key":"2570_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2023.107078","volume":"125","author":"MS LeBoff","year":"2023","unstructured":"LeBoff MS, Chou SH, Ratliff KA, Cook NR, Clar A, Holman B. Rationale and design of an ancillary study evaluating the effects of the cocoa flavanol and\/or multivitamin interventions on falls and physical performance outcomes in the COcoa supplement and multivitamin outcomes study (COSMOS). Contemp Clin Trials. 2023;125:107078.","journal-title":"Contemp Clin Trials"},{"issue":"3","key":"2570_CR29","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.ajcnut.2023.12.011","volume":"119","author":"CM Vyas","year":"2024","unstructured":"Vyas CM, Manson JE, Sesso HD, Cook NR, Rist PM, Weinberg A. Effect of multivitamin-mineral supplementation versus placebo on cognitive function: results from the clinic subcohort of the COcoa supplement and multivitamin outcomes study (COSMOS) randomized clinical trial and meta-analysis of 3 cognitive studies within COSMOS. Am J Clin Nutr. 2024;119(3):692\u2013701.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"2570_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/2150131916659282","volume":"8","author":"BM Kear","year":"2017","unstructured":"Kear BM, Guck TP, McGaha AL. Timed Up and Go (TUG) test: normative reference values for ages 20 to 59 years and relationships with physical and mental health risk factors. J Prim Care Community Health. 2017;8(1):9\u201313.","journal-title":"J Prim Care Community Health"},{"issue":"5","key":"2570_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/jbmrpl\/ziag041","volume":"10","author":"SH Chou","year":"2026","unstructured":"Chou SH, Cook N, Kim E, Kotler G, Ganz DA, Cawthon PM, et al. Effects of cocoa extract supplementation on physical performance measures: results from the randomized controlled COcoa supplement and multivitamin outcomes study. JBMR Plus. 2026;10(5): ziag041.","journal-title":"JBMR Plus"},{"issue":"3","key":"2570_CR32","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S0363-5023(96)80352-2","volume":"21","author":"RF Ashford","year":"1996","unstructured":"Ashford RF, Nagelburg S, Adkins R. Sensitivity of the Jamar dynamometer in detecting submaximal grip effort. J Hand Surg Am. 1996;21(3):402\u20135.","journal-title":"J Hand Surg Am"},{"issue":"2015","key":"2570_CR33","volume":"12","author":"T Paillard","year":"2015","unstructured":"Paillard T, No\u00e9 F. Techniques and methods for testing the postural function in healthy and pathological subjects. Biomed Res Int. 2015;12(2015): 891390.","journal-title":"Biomed Res Int"},{"issue":"4","key":"2570_CR34","doi-asserted-by":"publisher","first-page":"M221","DOI":"10.1093\/gerona\/55.4.M221","volume":"55","author":"JM Guralnik","year":"2000","unstructured":"Guralnik JM, Ferrucci L, Pieper CF, Leveille SG, Markides KS, Ostir GV. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci. 2000;55(4):M221\u201331.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"4","key":"2570_CR35","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/ageing\/afn101","volume":"37","author":"E Nordin","year":"2008","unstructured":"Nordin E, Lindel\u00f6f N, Rosendahl E, Jensen J, Lundin-Olsson L. Prognostic validity of the Timed Up-and-Go test, a modified Get-Up-and-Go test, staff\u2019s global judgement and fall history in evaluating fall risk in residential care facilities. Age Ageing. 2008;37(4):442\u20138.","journal-title":"Age Ageing"},{"key":"2570_CR36","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.cct.2015.01.007","volume":"41","author":"MS LeBoff","year":"2015","unstructured":"LeBoff MS, Yue AY, Copeland T, Cook NR, Buring JE, Manson JE. VITAL-Bone Health: rationale and design of two ancillary studies evaluating the effects of vitamin D and\/or omega-3 fatty acid supplements on incident fractures and bone health outcomes in the VITamin D and OmegA-3 TriaL (VITAL). Contemp Clin Trials. 2015;41:259\u201368.","journal-title":"Contemp Clin Trials"},{"key":"2570_CR37","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","volume":"117","author":"RB D\u2019Agostino Sr","year":"2008","unstructured":"D\u2019Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care. Circulation. 2008;117:743\u201353.","journal-title":"Circulation."},{"issue":"10","key":"2570_CR38","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1093\/gerona\/glaa284","volume":"76","author":"L He","year":"2021","unstructured":"He L, de Souto Barreto P, Giudici KV, Aggarwal G, Nguyen AD, Morley JE, et al. Cross-sectional and longitudinal associations between plasma neurodegenerative biomarkers and physical performance among community-dwelling older adults. J Gerontol A Biol Sci Med Sci. 2021;76(10):1874\u201381.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"2570_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanhl.2025.100715","volume":"6","author":"AM Ornago","year":"2025","unstructured":"Ornago AM, Pinardi E, Grande G, Valletta M, Calder\u00f3n-Larra\u00f1aga A, Andersson S. Blood biomarkers of Alzheimer\u2019s disease and 12-year muscle strength trajectories in community-dwelling older adults: a cohort study. Lancet Healthy Longev. 2025;6(5):100715.","journal-title":"Lancet Healthy Longev"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02570-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-026-02570-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02570-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:23:30Z","timestamp":1791998610000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-026-02570-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":39,"alternative-id":["2570"],"URL":"https:\/\/doi.org\/10.1007\/s11357-026-02570-8","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"assertion":[{"value":"4 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"TK reports having received research grants from the German Federal Joint Committee (G-BA) and personal compensation from the North-East German Society for Gynecological Oncology (NOGGO), AbbVie, the BMJ Group, and Frontiers Media S.A. JEM received investigator-initiated grants from Mars Edge, a segment of Mars Incorporated dedicated to nutrition research and products, for infrastructure support and donation of COSMOS study pills and packaging, and Pfizer Consumer Healthcare (now Haleon) for donation of COSMOS study pills and packaging during the conduct of the study. HDS received investigator-initiated grants from Mars Edge, a segment of Mars Incorporated dedicated to nutrition research and products, for infrastructure support and donation of COSMOS study pills and packaging, and Pfizer Consumer Healthcare (now Haleon) for donation of COSMOS study pills and packaging during the conduct of the study. Dr. Sesso additionally reported receiving investigator-initiated grants from Pure Encapsulations and honoraria and\/or travel for lectures from the Council for Responsible Nutrition, BASF, and NIH during the conduct of the study. PMR has received in-kind support (specifically donations of study pills and packing) from Mars Edge to be used in an NIH-funded, investigator-initiated trial. All other authors report no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}